Marshall Wace
PROF

Marshall Wace’s Profound Medical PROF Stock Holding History

Marshall Wace’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,801
Closed -$121K – 3066
2025
Q1 		$121K Sell
20,801
-15,415
-43% -$106K ﹤0.01% 2480
2024
Q4 		$272K Buy
36,216
+24,208
+202% +$186K ﹤0.01% 2263
2024
Q3 		$95.6K Buy
+12,008
New +$109K ﹤0.01% 2376
2021
Q4 		– Sell
-29,554
Closed -$433K – 4202
2021
Q3 		$433K Buy
+29,554
New +$450K ﹤0.01% 2460

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Marshall Wace's PROF Position: Q2 2025 in Review

Marshall Wace sold out of Profound Medical (PROF) in Q2 2025, closing a stake of 20,801 shares — an estimated $121K sold.

Marshall Wace first reported a position in PROF in Q3 2021 and held it in 4 quarters. The position peaked at $433K in Q3 2021. 44 funds tracked by Wall St. Rank hold PROF as of Q2 2025.

  • Marshall Wace reported no remaining Profound Medical position as of Q2 2025 after selling out during the quarter.
  • Marshall Wace sold 20,801 Profound Medical shares in Q2 2025, an estimated $121K.
  • Marshall Wace first reported a position in Profound Medical in Q3 2021 and held it in 4 quarters.
  • Marshall Wace's Profound Medical position peaked at $433K in Q3 2021.
  • 44 funds tracked by Wall St. Rank held Profound Medical as of Q2 2025.

Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.